Gilead Sciences has now formally closed its previously disclosed deal to acquire Tubulis GmbH, the Germany-based clinical-stage biopharmaceutical company dedicated to developing the next...
Concept Life Sciences, a leading global contract research organization (CRO) with expertise in integrated drug discovery and development, and OpenBench, a pioneer of success-based...
At the BIO-IT World Conference & Expo 2026, QIAGEN revealed that its bioinformatics arm, QIAGEN Digital Insights, will be leveraging NVIDIA accelerated computing and...
ATB Therapeutics a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The...
LOTTE Biologics has its antibody manufacturing deal with Ottimo Pharma, an emerging strategic partner in developing cutting-edge therapies for oncology. The expanded manufacturing collaboration...
